Priority Research Area Chronic Lung Diseases

DZL Laboratory for Experimental Microbiome Research

Mission   Projects   Funding    Techniques  Publications    Staff



Chen, J, Wang, X, Schmalen, A, Haines, S, Wolff, M, Ma, H, Zhang, H, Stoleriu, MG, Nowak, J, Nakayama, M, Bueno, M, Brands, J, Mora, AL, Lee, JS, Krauss-Etschmann, S, Dmitrieva, A, Frankenberger, M, Hofer, TP, Noessner, E, Moosmann, A, Behr, J, Milger, K, Deeg, CA, Staab-Weijnitz, CA, Hauck, SM, Adler, H, Goldmann, T, Gaede, KI, Behrends, J, Kammerl, IE & Meiners, S 2023, 'Antiviral CD8+ T cell immune responses are impaired by cigarette smoke and in COPD', The European respiratory journal, Jg. 62, Nr. 2, 2201374.

GEN-COVID Multicenter Study Group 2023, 'CYP19A1 mediates severe SARS-CoV-2 disease outcome in males', Cell reports. Medicine, S. 101152.



Ehrhardt, B, Krauss-Etschmann, S, Schramm, J, Kovacevic, D, El-Merhie, N, Roeder, T & Bossen, J 2022, 'Airway remodeling: The Drosophila model permits a purely epithelial perspective', Frontiers in Allergy, Jg. 3, S. 876673.

Pfeiffer, S, Jatzlauk, G, Lund, JV, Boateng, E, Kovacevic, D, N Hylkema, M, Bartel, S, Schloter, M & Krauss-Etschmann, S 2022, 'Oral application of vancomycin alters murine lung microbiome and pulmonary immune responses', Immunity, inflammation and disease, Jg. 10, Nr. 8, S. e675.



Lund, J, Kovacevic, D, Schloter, M & Krauss-Etschmann, S 2020, 'Rolle der mikrobiellen Darm-Lungen-Achse für die Lungengesundheit: Mikrobiom – Darm-Lungen-Achse – Lungenerkrankungen – bakterielle Metabolite', Pädiatrische Praxis, Jg. 93 / 3, S. 444-452.

Pfeiffer, S, Herzmann, C, Gaede, KI, Kovacevic, D, Krauss-Etschmann, S & Schloter, M 2021, 'Different responses of the oral, nasal and lung microbiomes to cigarette smoke', Thorax.